Tag Archives: Healthcare

Events, Opportunities, other events, PhD/post doctoral

2025 LCRF RESEARCH GRANT ON PREVENTION AND EARLY DETECTION IN LUNG CANCER

Leave a comment

Application Deadline: March 3, 2025

LOCATION: USA

Given the significance and need for early detection of lung cancer and advancements in molecular screening, LCRF continues to offer a funding mechanism to support research projects that facilitate or advance the understanding and characterization of approaches for early detection of lung cancer. Work supported through this mechanism addresses important questions in non-small cell and small cell lung cancer.

ELIGIBILITY:

Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.

Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.

Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.

Applicants are prohibited from applying in more than one of LCRF’s funding tracks in the same cycle.

Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process.

However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics. Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office (see Inquiries section below) before submitting an application and at least a week before submission deadline. Ineligible applications and new requests under special circumstances will not be considered after submission deadline.

BENEFIT:

These awards provide a maximum of $150,000 in funding over a period of two years. Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.

APPLY
awards, Events, Opportunities, other events

PRIX GALIEN AFRICA FOR PHARMACEUTICAL RESEARCHERS AND INSTITUTIONS/INDUSTRIES ($30,000 AWARD)

Leave a comment

Application Deadline: Wednesday July 31, 2024 at 23:59 p.m. (UTC/GMT)

LOCATION: Senegal

In partnership with the Galien Foundation, the Association Galien Africa is launching a call for applications for the 4th edition of the “Prix Galien Africa” which rewards excellence and innovation. It aims to reward researchers, institutions and pharmaceutical industries from the public or private sector that have successfully developed initiatives, ser vices, pharmaceutical, biotechnological, phytotherapy, diagnostic products and medical devices recently introduced on the African market.

ELIGIBILITY:

The “Prix Galien Africa” rewards pharmaceutical and phytotherapy sciences that improve the human condition, mainly on the basis of the following criteria:

Innovation and/or discovery

Impact on the African continent.

Collaboration with an African institution for products presented by non-African institutions

In applying for one of the prizes below, the applicant agrees with the provisions of the “Prix Galien Africa” Charter, which is available and can be downloaded from the website: https://prixgalienafrique.com/.

The “Prix Galien Africa” is open to researchers, institutions and pharmaceutical industries from the public or private sector, having developed pharmaceutical, biotechnological, phytotherapy, diagnostic products and medical devices, marketed in the African countries and having obtained the mar keting authorization (MA), delivered by at least one African pharmaceutical regulatory authority.

Pharmaceutical, biotechnological, herbal medicine, diagnostic and medical devices must be based on innovative science, developed by synthetic chemistry or molecular biology or manufactured naturally with plants according to precise criteria, specifications, tested in controlled clinical trials and marketed by ethical pharmaceutical companies.

The initial marketing authorization must be valid for a maximum of five years as of December 31 of the competition year. Exemptions could be granted for digital technology or solutions and for Traditional therapy products. As the MA is not applicable to digital technology or solutions and Traditional therapy, the selection criteria are defined by an assessment grid drawn up by the Jury.

Attachments to the application form:

Letter of application (maximum one page)

CV (maximum two pages) and legalized copy of diplomas for individual applications

Summary of the institution description for institutional applications (maximum one page)

Full description of the product or device and its impact on the African continent (maximum two pages)

Marketing authorization for the product or device (if applicable)

BENEFIT:

The prize categories to be awarded are:

the best pharmaceutical product,

the best traditherapy product,

the best biotechnology product,

the best medical technology or digital solution (medical device, diagnostic, e-health, telemedicine, patient records, etc.)

Each prize is endowed with a 20,000,000 FCFA (Twenty Million Cfa Francs) grant, or about 30,000 USD (Thirty Thousand US Dollars).

APPLY